Integrative Updates on Memory, Cognition and Alzheimer’s Disease

Have you ever heard of anyone preventing their memory decline way before it actually presents as dementia? The truth is, dementia is a very big problem that’s becoming bigger every day.

In 2023, it is estimated there are more than 400,000 Australians living with dementia and more than 1.5 million people are caring for someone living with dementia.

Alzheimer’s disease, a growing epidemic, is the most common form of dementia. It is a physical brain condition resulting in impaired memory, thinking and behaviour. It disrupts the brain’s neurons, affecting how they work and communicate with each other.

Research has shown that amyloid-β is deposited in E4 carriers as early as their thirties, so addressing components prior to experiencing cognitive impairment symptoms will likely lead to better health and cognition in aging.

Dr Dale Bredesen suggests that the molecular switch that promotes Alzheimer’s disease is turned on in response to three major metabolic insults and has identified three types of Alzheimer’s disease that have unique presentations and associated risks.

A new approach is needed. The drivers of neuro-inflammation must be managed in order to prevent cognition decline

What are the tell tale signs of Cognition decline?

The early signs of Alzheimer’s disease can be subtle and may go unnoticed at first. As the disease progresses, the symptoms become more pronounced and disruptive to daily life.

Some of the early signs of Alzheimer’s disease include:

• Memory loss that disrupts daily life. This is the most common symptom of Alzheimer’s disease. People with Alzheimer’s may forget recent events, conversations, or appointments. They may also have difficulty remembering names, directions, or how to use familiar objects.
• Challenges in planning or solving problems. People with Alzheimer’s may have difficulty making decisions, solving problems, or planning activities. They may also have trouble following instructions or keeping track of multiple tasks.
• Difficulty completing familiar tasks. People with Alzheimer’s may have difficulty performing familiar tasks, such as cooking, dressing, or driving. They may also have trouble organizing their thoughts and expressing themselves clearly.
• Confusion with time or place. People with Alzheimer’s may become confused about the time of day, day of the week, or where they are. They may also get lost in familiar places.
• Trouble understanding visual images and spatial relationships. People with Alzheimer’s may have trouble understanding visual images, such as maps or pictures. They may also have difficulty judging distances or spatial relationships.
• New problems with words in speaking or writing. People with Alzheimer’s may have difficulty finding the right words or understanding the meaning of words. They may also have trouble writing clearly or following written instructions.
• Misplacing things and losing the ability to retrace steps. People with Alzheimer’s may misplace things and have difficulty remembering where they put them. They may also lose the ability to retrace their steps to find something they have lost.
• Decreased or poor judgment. People with Alzheimer’s may make poor decisions, such as giving away money or driving when they are no longer safe to do so.
• Withdrawal from work or social activities. People with Alzheimer’s may withdraw from work or social activities that they used to enjoy. They may also become isolated and withdrawn from family and friends.
• Changes in mood and personality. People with Alzheimer’s may experience changes in mood, such as becoming depressed, anxious, or irritable. They may also experience changes in personality, such as becoming more withdrawn or suspicious.

Test for Memory Loss, Alzheimer’s, Dementia, Cognition Decline

Educational Webinar

In this webinar, you will learn

➡ Are you at risk of Alzheimer’s disease?

➡ Causes of memory decline

➡ Types of Alzheimer’s disease

➡ Assessment of cognition decline

➡ Therapeutic options in management of memory problems

Boosting BDNF in Alzheimer’s Disease